It is noteworthy that several polymorphisms have been defined that cause decreased expression of NF-κB1 in different human malignancies, such as epithelial tumors [63] and gastric cancer [64], as well as in autoimmune diseases [65]. Here, NFKB1 is linked to gastric cancer.